JP Morgan Chase
WST icon

JP Morgan Chase’s West Pharmaceutical WST Stock Holding History

JP Morgan Chase’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$65.5K – 7777
2024
Q4 		$65.5K Sell
200
-700
-78% -$220K ﹤0.01% 5912
2024
Q3 		$270K Hold
900
– – ﹤0.01% 5264
2024
Q2 		$296K Sell
900
-3,800
-81% -$1.34M ﹤0.01% 4946
2024
Q1 		$1.86M Hold
4,700
– – ﹤0.01% 3899
2023
Q4 		$1.65M Buy
+4,700
New +$1.66M ﹤0.01% 3976
2022
Q4 		– Sell
-600
Closed -$148K – 7049
2022
Q3 		$148K Buy
+600
New +$183K ﹤0.01% 5095

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

JP Morgan Chase's WST Position: Q2 2026 in Review

JP Morgan Chase increased its West Pharmaceutical (WST) stake by 12% in Q2 2026, buying an estimated $37M and bringing the position to 1,164,527 shares worth $413M. The position accounts for 0.02% of the portfolio, ranked #506.

JP Morgan Chase first reported a position in WST in Q2 2013 and has held it in 53 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • JP Morgan Chase held 1,164,527 shares of West Pharmaceutical worth $413M as of Q2 2026.
  • JP Morgan Chase bought 121,110 West Pharmaceutical shares in Q2 2026, an estimated $37M.
  • West Pharmaceutical made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #506 holding.
  • JP Morgan Chase first reported a position in West Pharmaceutical in Q2 2013 and has held it in 53 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.